Results 141 to 150 of about 23,536 (264)

Evidence of dual sexual transmission of multi-resistant HIV with two years persistence of resistance to NRTI and NNRTI: a case report

, 2008
A case report of dual sexual transmission, with secondary transmission from naïve to naïve patient, of HIV harbouring K103N and L100I mutations, conferring full non-nucleoside reverse transcriptase inhibitor (NNRTI) resistance, plus 2 nucleoside ...
Mosti, S, Acinapura, R, Antinori, A., Ammassari, A, Marconi, P, Visco-Comandini, U, Perno, C, Zaccarelli, M, Sette, P, PERNO, CARLO FEDERICO, Visco Comandini, U, Antinori, A, Liuzzi, G   +12 more
core   +1 more source

Nonnucleoside RT Inhibitor (NNRTI) Resistance Mutations: Percent Occurrence in Patients Treated with Dual nucleoside RT inhibitor (NRTI) plus NNRTI First Line Antiretroviral (ARV) Regimens.

, 2013
Footnote: *No.: Number of patients receiving first-line therapy with the ARV regimen indicated in the first two columns.†The proportion of individuals treated with NVP or EFV. Mutations for which there were statistically significant differences according
Gert U. Van Zyl (427181), Tulio de Oliveira (68362), Robert W. Shafer (32534), Natasha T. Wood (427184), Susan Engelbrecht (427183), Simon Travers (427185), Tommy F. Liu (374095), Mathilda Claassen (427182), Wolfgang Preiser (17927)   +8 more
core   +1 more source

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing [PDF]

, 2017
Objectives It is still debated if pre-existing minority drug-resistant HIV-1 variants (MVs) affect the virological outcomes of first-line NNRTI-containing ART.
Ceccherini-Silberstein, Francesca, Michalik, Claudia, Kouyos, Roger D., Brockmeyer, Norbert, Cozzi-Lepri, Alessandro, D'Arminio Monforte, Antonella, Aitken, Sue, Paredes, Roger, Noguera-Julian, Marc, Di Giallonardo, Francesca, Geretti, Anna Maria, Bellecave, Pantxika, Günthard, Huldrych F., Furrer, Hansjakob, Booth, Clare L., Castro, Erika, Schuurman, Rob, Kaiser, Rolf, Brun-Vezinet, Francoise, Metzner, Karin J., Jansen, Klaus, Günthard, Huldrych, Schultze, Anna, Masquelier, Bernard, Däumer, Martin   +24 more
core  

NNRTI and other class resistance in treatment-naïve patients in North America and Western Europe [12,13].

, 2013
NNRTI and other class resistance in treatment-naïve patients in North America and Western Europe [12,13].
Katherine Nedrow (449577), Richard Chambers (449578), Congyu Li (449579), Sonya J. Snedecor (449575), Alexandra Khachatryan (449576), Seema Haider (449580), Jennifer Stephens (449581)   +6 more
core   +1 more source

Switching to the single-tablet regimen of elvitegravir, cobicistat, emtricitabine, and tenofovir DF from non-nucleoside reverse transcriptase inhibitor plus coformulated emtricitabine and tenofovir DF regimens: Week 96 results of STRATEGY-NNRTI

HIV Clinical Trials, 2017
A. Pozniak, J. Flamm, A. Antinori, M. Bloch, D. Ward, J. Berenguer, P. Cote, Kristen Andreatta, W. Garner, J. Szwarcberg, T. Nguyen-Cleary, D. Mccoll, D. Piontkowsky   +12 more
semanticscholar   +1 more source

Switching to Daily Doravirine/Islatravir (100/0.25 mg) Maintains Viral Suppression Through Week 48 Despite Baseline Non-Nucleoside Reverse Transcriptase Inhibitor Resistance-Associated Mutations or M184I/V in Proviral DNA. [PDF]

J Infect Dis
Diamond TL, Grandhi A, Fuszard M, Xu Y, Nwoke U, Zhang Y, Klopfer SO, Eves K, Benner J, Li M, Greaves W, Lahoulou R, Kim J, Fox MC, Asante-Appiah E.   +14 more
europepmc   +1 more source

Understanding viral blips in people with HIV on antiretroviral therapy: a nationwide Swedish cohort study of 4,210 individuals. [PDF]

BMC Infect Dis
Sörstedt E, Nilsson S, Sönnerborg A, Carlander C, Treutiger CJ, Månsson F, Änghagen L, Berggren H, Gisslén M, Yilmaz A.   +9 more
europepmc   +1 more source

Prevalence and transmission of pretreatment drug resistance and acquired drug resistance among people living with HIV-1 in Chongqing, China, 2014-2024. [PDF]

Front Public Health
Gao W, Li J, Li M, He K, Deng R, Yang K.
europepmc   +1 more source

Age-Driven Cardiovascular Risk Scores Differ Across Antiretroviral Regimens Among People Living with HIV in the Colombian Caribbean Region. [PDF]

Infect Dis Rep
Parejo Garay SP, Gómez Perdomo JA, Martínez Bula EA, Iglesias Pertuz SP, Daguer Reyes SP, Dominguez Vargas A, González-Torres HJ.   +6 more
europepmc   +1 more source

HIV-1 genotypic patterns in antiretroviral-naïve and treated patients in the integrase inhibitor era in Morocco. [PDF]

BMC Infect Dis
Ahmina M, Annaz HE, Reggad A, Lamrak N, Tagajdid MR, Abi R, Elqatni M, Laraqui A, Elkochri S, Bouaiti E, Amraoui FE, Elbnaissi Y, Hamdouni I, Mchichi BE, Touil N, Ennibi K, Amine Lahlou I.   +16 more
europepmc   +1 more source